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Background and Purpose We aimed to develop a model predicting early recanalization after in-
travenous tissue plasminogen activator (t-PA) treatment in large-vessel occlusion.
Methods Using data from two different multicenter prospective cohorts, we determined the fac-
tors associated with early recanalization immediately after t-PA in stroke patients with large-ves-
sel occlusion, and developed and validated a prediction model for early recanalization. Clot volume 
was semiautomatically measured on thin-section computed tomography using software, and the 
degree of collaterals was determined using the Tan score. Follow-up angiographic studies were 
performed immediately after t-PA treatment to assess early recanalization.
Results Early recanalization, assessed 61.0±44.7 minutes after t-PA bolus, was achieved in 15.5% 
(15/97) in the derivation cohort and in 10.5% (8/76) in the validation cohort. Clot volume (odds 
ratio [OR], 0.979; 95% confidence interval [CI], 0.961 to 0.997; P=0.020) and good collaterals (OR, 
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Introduction
Successful recanalization in acute stroke patients with large-ves-
sel occlusion (LVO) is a main target of reperfusion therapy. To 
achieve early and complete successful recanalization, early 
treatment with either intravenous tissue plasminogen activator 
(IV t-PA) or endovascular treatment (EVT) is needed.1,2
Even after the successful introduction of EVT, bridging thera-
py with IV t-PA is recommended before EVT.2 However, IV t-PA 
treatment has low successful recanalization rates in patients 
with LVO.3-5 In addition, bridging therapy with IV t-PA before 
EVT may delay the initiation of EVT or increase the risk of 
bleeding complications, which may lead to unfavorable out-
comes.6 In contrast, early recanalization that can be achieved 
with IV t-PA may be beneficial for outcomes.7 Although bridg-
ing therapy with IV t-PA is currently a debated issue,8 a specific 
group of patients may benefit from IV t-PA before EVT and se-
lection of good responders would be helpful for improving pa-
tient outcomes.
A large clot burden determined either quantitatively or qual-
itatively is strongly associated with successful recanalization 
after IV t-PA treatment.5,9-13 In our previous study, almost all 
patients with thrombus measuring >200 mm3 did not achieve 
early recanalization after IV t-PA; these patients were suggest-
ed to be the primary candidates for direct EVT.5 However, many 
patients had thrombus measuring <200 mm3, and approxi-
mately 70% of them still did not achieve early recanalization. 
Furthermore, predicting patients who might achieve early re-
canalization after IV t-PA would be helpful for deciding IV t-PA 
treatment in those with LVO. This suggests the necessity of an 
improved model that predicts not only nonrecanalization but 
also successful recanalization.
While a clot burden is associated with early recanalization, 
the collateral status may also have a role.14 The presence of 
good collaterals is an indicator of a favorable outcome in pa-
tients undergoing recanalization treatment.15 Although aiding 
in keeping the penumbra area durable until achieving recanali-
zation is the main reason, an enhanced thrombolytic effect by 
delivering more t-PA to the clot via backflow may also contrib-
ute to the favorable outcome.14,16 Therefore, we aimed to deter-
mine the predictors of early recanalization after IV t-PA treat-
ment, including both clot volume and the degree of collaterals. 
We also aimed to develop and validate a simple prediction 




We used data from two different multicenter stroke registries 
for developing a prediction model. For the derivation cohort, 
we used data from the Thrombus Imaging Study registry, which 
was a multicenter prospective study designed to provide clini-
cal evidence for thrombus imaging for outcome prediction in 
reperfusion therapy.5 The inclusion criteria were treatment with 
IV t-PA within 4.5 hours of symptom onset and visible thrombi 
at the occlusion site of the distal internal carotid artery (ICA) 
and/or middle cerebral artery (MCA) on thin-section noncon-
trast computed tomography (NCCT). Patients were consecu-
tively enrolled between February 2016 and August 2017 from 
nine hospitals.5 In this analysis, we included 97 patients with 
visible thrombus at the distal ICA or MCA (Figure 1).
For the validation cohort, we used data from the Selection 
Criteria in Endovascular Thrombectomy and Thrombolytic Ther-
apy (SECRET) registry (Clinicaltrials.gov: NCT02964052).17 The 
SECRET registry is a nationwide multicenter registry for explor-
ing the selection criteria for patients who would benefit from 
reperfusion therapies. This study included 1,026 patients who 
6.129; 95% CI, 1.592 to 23.594; P=0.008) were significant factors associated with early recanali-
zation. The area under the curve (AUC) of the model including clot volume was 0.819 (95% CI, 
0.720 to 0.917) and 0.842 (95% CI, 0.746 to 0.938) in the derivation and validation cohorts, re-
spectively. The AUC improved when good collaterals were added (derivation cohort: AUC, 0.876; 
95% CI, 0.802 to 0.950; P=0.164; validation cohort: AUC, 0.949; 95% CI, 0.886 to 1.000; P=0.036). 
The integrated discrimination improvement also showed significantly improved prediction (0.097; 
95% CI, 0.009 to 0.185; P=0.032).
Conclusions The model using clot volume and collaterals predicted early recanalization after intra-
venous t-PA and had a high performance. This model may aid in determining the recanalization 
treatment strategy in stroke patients with large-vessel occlusion.
Keywords Ischemia; Stroke; Thrombosis; Thrombolysis; Reperfusion
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had been registered retrospectively from 15 hospitals between 
January 2012 and December 2015 and 333 patients who had 
been registered prospectively from 13 hospitals between No-
vember 2016 and December 2017. There were 98 patients with 
visible thrombi in the distal ICA and/or MCA on initial thin-sec-
tion NCCT and those with imaging data available before and 
after IV t-PA. However, there was an overlap of the study peri-
od between the Thrombus Imaging Study and the SECRET 
study. Therefore, we excluded 22 patients (anonymized) who 
were enrolled during the overlapped period. Finally, 76 patients 
were included for the validation (Figure 1). This study was ap-
proved by the Institutional Review Board of each study hospi-
tal, and written informed consent was obtained from all pa-
tients enrolled prospectively.
Imaging protocol and reperfusion therapy
The patients included in this study underwent thin-section (1 
or 1.25 mm) NCCT and computed tomography angiography 
(CTA) before IV t-PA. All patients were treated with IV t-PA 
(Actilyse, Boehringer-Ingelheim, Ingelheim, Germany) at a 
standard dose of 0.9 mg/kg (10% as a bolus followed by 90% 
as an infusion for 60 minutes) within 4.5 hours of stroke onset. 
The inclusion and exclusion criteria for IV t-PA treatment were 
based on the guidelines, which were not different among the 
study hospitals. Further EVT was sequentially performed if the 
patients did not show clinical improvement or did not achieve 
arterial recanalization after IV t-PA treatment. Follow-up CTA 
or magnetic resonance angiography (MRA) was immediately 
performed after the end of IV t-PA if the patients were not 
treated with EVT.
Assessment of imaging findings
The volume and density of thrombus were semiautomatically 
measured on baseline thin-section NCCT using three-dimen-
sional software (Xelis, Infinitt, Seoul, Korea). The detailed 
methods have been previously described.5,18,19 Briefly, when a 
hyperdense artery (pixels between 50 and 100 Hounsfield 
units) was identified on thin-section NCCT, this thrombus area 
was automatically shown as a red area. When clicking any por-
tion within the thrombus area and subsequently the “Dilate” 
icon, every slice of thrombus was merged with automatic pixel 
dilation and region growing. Thereafter, the volume and density 
of the thrombus were shown on a screen within 1 minute by 
automatic calculation. Simultaneously, CTA maximum-intensi-
ty projection images and thin-section NCCT images could be 
synchronized on a screen, which could enable the easy identi-
fication of thrombus.
The presence of early recanalization was assessed on CTA or 
1,359 Patients enrolled in the SECRET registry
76 Patients included
641 Patients without occlusive lesion at 
MCA or distal ICA
283 Patients who did not receive IV t-PA
22 Patients who were enrolled in the 
thrombus imaging study
8 Patients whose collateral status could 
not be assessed
329 Patients whose thrombus data 
could not be collected because of 
1) no thin-section noncontrast CT;
2) no visible thrombus;
3) poor image quality
B
123 Patients enrolled in the thrombus imaging study
97 Patients included
17 Patients without occlusive lesion 
at MCA or distal ICA
2 Patients with the multiple occlusions
4 Patients with poor image quality
3 Patients without follow-up 
angiography after IV t-PA
A
Figure 1. Patient selection: (A) derivation cohort, (B) validation cohort. MCA, middle cerebral artery; ICA, internal carotid artery; IV t-PA, intravenous tissue 
plasminogen activator; SECRET, Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy; CT, computed tomography.
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MRA images taken immediately at the end of IV t-PA or on 
digital subtraction angiography images taken during EVT. Suc-
cessful recanalization was defined as a modified Thrombolysis 
in Cerebral Infarction (TICI) grade of 2b or 3 on digital sub-
traction angiography20 or an arterial occlusive lesion score of 
3 on CTA or MRA. We also determined the degree of collater-
als using the Tan collateral score11,16 based on the single-phase 
CTA axial image performed before IV t-PA treatment, and the 
presence of good collaterals was defined as a Tan score of 3. 
We also collected the Alberta Stroke Program Early CT score. 
Two stroke neurologists (Y.D.K. and J.Y.) measured the throm-
bus volume and density and determined the Tan score, Alberta 
Stroke Program Early CT score, and TICI grade. Entire imaging 
analyses were independently performed without knowledge of 
any clinical information. In the case of discrepancies, a con-
sensus was reached for the derivation cohort and adjudicated 
by the imaging adjudication committee for the validation co-
hort.
Clinical variables
We collected data on demographics, risk factors, and premor-
bid disability (dependent status defined as a modified Rankin 
Scale score of 3–5). Time parameters such as the intervals from 
stroke onset to initial brain imaging, from onset to IV t-PA, and 
from the initiation of IV t-PA to follow-up angiographic studies 
were determined. Data on the total dose of t-PA for each pa-
tient were collected. The stroke severity was assessed using the 
National Institutes of Health Stroke Scale.
Statistical analyses
Data are presented as frequency (percentage) for categorical 
variables and mean±standard deviation or median (interquartile 
range) for continuous variables. Differences between the groups 
were assessed using Student’s t-test or the Mann-Whitney 
U-test for continuous variables and the chi-square test or Fish-
er’s exact test for categorical variables, as appropriate.
Univariable and multivariable logistic regression analyses 
were performed to determine the independent factors for early 
successful recanalization after IV t-PA. The collinearity of com-
binations of variables in the derivation cohort was evaluated 
using variation inflation factors (<2 being considered nonsig-
nificant). Odds ratios (ORs) with 95% confidence intervals (CIs) 
for each variable included in the model were finally calculated. 
On the basis of the results of multivariable logistic regression 
analysis, we developed a prediction model and a nomogram.
We compared the predictive ability between the model in-
cluding clot volume only and the model in which the presence 
of good collaterals was added to clot volume by computing the 
area under the curve (AUC) using the Delong method. The inte-
grated discrimination improvement (IDI) index was computed 
to investigate whether adding the presence of good collaterals 
to clot volume would improve the predictive power. We also 
plotted decision curves to assess the net benefit of nomo-
gram-assisted decisions.
We examined the calibration (calibration plots and Hos-
mer-Lemeshow test) and discrimination (AUC). To assess the 
external validity of model performance, we applied our predic-
tion model to the validation cohort. We examined the perfor-
mance of the final model both in the derivation and external 
validation cohorts in terms of discrimination using AUC and in 
terms of calibration by plotting the agreement between the 
predicted and observed probabilities across the quartiles of 
scores. In addition, we determined the optimal cutoff value of 
the prediction value based on nomogram, which was verified 
by calculating the Youden index.
Statistical analyses were performed using R software pack-
age version 3.6.2 (http://www.R-project.org). All statistical tests 
were two-tailed; P<0.05 was considered statistically signifi-
cant, whereas 0.05≤P<0.2 was considered a trend toward sig-




Follow-up angiographic studies were performed at a mean of 
61.0±44.7 minutes after the bolus injection of t-PA (65.1±49.1 
minutes in the derivation cohort and 55.9±38.1 minutes in the 
validation cohort, P=0.181). The baseline characteristics includ-
ing clot volume and the frequency of good collaterals were not 
different between the derivation and validation cohorts, except 
diabetes and dyslipidemia, which had lower frequencies in the 
derivation cohort (Table 1).
Determinants for successful recanalization
The occluded artery was recanalized immediately after IV t-PA 
in 15.5% (15/97) of the derivation cohort and in 10.5% (8/76) 
of the validation cohort. The factors associated with early reca-
nalization in the derivation cohort were smaller clot volumes, 
good collaterals, and lower National Institutes of Health Stroke 
Scale scores on univariable analysis. Multivariable logistic re-
gression analysis showed that clot volume (OR, 0.979 per 1 
mm3; 95% CI, 0.961 to 0.997; P=0.02) and good collaterals 
(OR, 6.129; 95% CI, 1.592 to 23.594; P=0.008) were indepen-
dent and significant predictors of early recanalization (Table 2). 
These findings were still observed when we divided the study 
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https://doi.org/10.5853//jos.2020.03622248 http://j-stroke.org
Table 1. Baseline characteristics of the derivation and external validation cohorts
Characteristic Derivation cohort (n=97) Validation cohort (n=76) P
Age (yr) 67.9±12.8 66.9±10.8 0.620
Male sex 44 (45.4) 39 (51.3) 0.437
Hypertension 58 (59.8) 54 (71.1) 0.124
Diabetes 27 (27.8) 40 (52.6) 0.001
Dyslipidemia 28 (28.9) 34 (44.7) 0.031
Atrial fibrillation 46 (47.4) 46 (60.5) 0.086
Previous stroke 15 (15.5) 15 (19.7) 0.461
Premorbid disability 1 (1.0) 3 (3.9) 0.321
Sequential endovascular treatment 73 (75.3) 59 (77.6) 0.716
Occlusion site 0.727
Distal ICA±M1 21 (21.6) 20 (26.3)
MCA M1 59 (60.8) 42 (55.3)
MCA M2 17 (17.5) 14 (18.4)
Initial NIHSS score 15 (11–18) 14 (9–19) 0.736
ASPECT score 8 (7–9) 8 (7–9) 0.306
t-PA dose (mg) 54.3±12.7 54±10 0.887
Onset to t-PA 123.1±66.2 123.4±80.1 0.974
Onset to CT 102.3±65.7 100.2±78.4 0.843
t-PA to follow-up imaging 65.1±49.1 55.9±38.1 0.181
Thrombus volume (mm3) 124.7±102.1 144.3±122.8 0.253
Thrombus HU 51.5±3.5 52.6±3.6 0.038
Good collaterals, 3 vs. 0–2 31 (32.0) 15 (19.7) 0.071
Values are presented as mean±standard deviation, number (%), or median (interquartile range). 
ICA, internal carotid artery; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; ASPECT, Alberta Stroke Program Early Computed 
Tomography; t-PA, tissue plasminogen activator; CT, computed tomography; HU, Hounsfield unit.
Table 2. Univariable and multivariable analyses for early recanalization
Variable
Univariable analysis Multivariable analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P
Age 0.968 (0.929–1.008) 0.117
Male sex 0.496 (0.162–1.524) 0.221
Hypertension 3.130 (0.821–11.934) 0.095
Diabetes 1.364 (0.419–4.435) 0.606
Dyslipidemia 0.570 (0.148–2.198) 0.414
Atrial fibrillation 0.700 (0.228–2.146) 0.533
Previous stroke 2.347 (0.634–8.688) 0.201
Premorbid disability 0.000 (0.000–NA) 1.000
Initial NIHSS score 0.882 (0.797–0.976) 0.015 0.963 (0.852–1.089) 0.551
ASPECT score 1.458 (0.933–2.279) 0.098
t-PA dose (mg) 1.010 (0.965–1.056) 0.670
Onset to t-PA 0.999 (0.991–1.008) 0.886
Onset to CT 1.000 (0.992–1.009) 0.928
t-PA to follow-up imaging 1.004 (0.995–1.013) 0.394
Clot volume (mm3) 0.976 (0.961–0.992) 0.004 0.979 (0.961–0.997) 0.020
Clot HU 0.873 (0.744–1.023) 0.094
Good collateral, 3 vs. 0–2 8.525 (2.441–29.769) 0.001 6.129 (1.592–23.594) 0.008
CI, confidence interval; NA, not applicable; NIHSS, National Institutes of Health Stroke Scale; ASPECT, Alberta Stroke Program Early Computed Tomography; 
t-PA, tissue plasminogen activator; CT, computed tomography; HU, Hounsfield unit.
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population into two groups based on the timing (≥45 or ≤75 
minutes) of follow-up angiographic studies after IV t-PA (Sup-
plementary Table 1).
As the clot volume was a strong factor associated with early 
recanalization, we determined whether adding good collaterals 
to the prediction model would improve the model performance. 
When the presence of good collaterals was added to clot vol-
ume, the AUC improved from 0.819 (95% CI, 0.720 to 0.917) to 
0.876 (95% CI, 0.802 to 0.950) in the derivation cohort 
(P=0.164) (Figure 2A) and from 0.842 (95% CI, 0.746 to 0.938) 
to 0.949 (95% CI, 0.886 to 1.000) in the validation cohort 
(P=0.036). The decision curves for the probability of successful 
recanalization in the derivation cohort showed better perfor-
mance when the presence of good collaterals was added to 
clot volume (Figure 2B). The computation of IDI also showed 
significantly improved prediction (IDI, 0.097; 95% CI, 0.009 to 
0.185; P=0.032). The Hosmer-Lemeshow tests were not signifi-
cant in the derivation cohort (P=0.970) and the validation co-
hort (P=0.935), which means a good fit. Figure 3 demonstrates 
the predicted versus observed probability based on the quartile 
of the scores, which showed good correlation.
Accordingly, we developed a model predicting early recanali-
zation after IV t-PA treatment using both clot volume and 
good collaterals. For easy use of the prediction model, we also 
developed a nomogram predicting early recanalization by as-
signing a graphic score to each of clot volume and good collat-
erals, with a point range from 0 to 20. The scores were summed 
to generate a total score, which was finally converted into an 
individual probability of early successful recanalization after IV 
t-PA (Figure 4). Higher total points based on the sum of the 
assigned number of points for good collaterals and clot volume 
were associated with the chance of early recanalization (Sup-
plementary Figure 1). The cut off value of >0.1107 of the pre-
diction model value for predicting early recanalization, which 
was based on the Youden index, had good sensitivity (100%) 
and specificity (68.3%).
Discussion
In the present study, early recanalization after IV t-PA was sig-
nificantly associated with clot volume and collateral status 
(thus, the model was named “2C”). The prediction model using 
both clot volume and good collaterals could reliably predict 
early recanalization after IV t-PA treatment among patients 
with LVO. This 2C model was externally validated using another 
population enrolled in a nationwide multicenter registry. We 
also developed a nomogram using these two variables for rapid 
and easy use in clinical practice, which can help identify pa-
tients who would be expected to achieve early recanalization 
after IV t-PA treatment.
With EVT becoming the standard treatment, bridging therapy 
with IV t-PA before EVT in patients with LVO is a debated is-
sue.8 This is because, in patients with LVO, recanalization is 
achieved immediately after t-PA in only about 10% to 
15%4,5,13,14,19,21 and t-PA may increase the risk of bleeding and 
distal embolization of partially lysed clots. It may also delay the 
begin.
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Figure 2. Comparison of receiver operating characteristic (ROC) curves between two models (A) and decision curve analysis (B). (A) ROC curves of the deriva-
tion cohorts and area under the curve (AUC) values (model using only clot volume, 0.819; model using both clot volume and good collaterals, 0.876). (B) Deci-
sion curve analysis showing that the model using both clot volume and good collaterals was the preferred model.
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Figure 3. Assessment of discrimination and calibration in the derivation cohort (A, B) and the validation cohort (C, D). (A) Receiver operating characteristic 
(ROC) curves of the derivation cohort and area under the curve (AUC) values (AUC, 0.876; 95% confidence interval [CI], 0.802 to 0.950). (B) Calibration plot 
per quartile of the scores in the derivation cohort. (C) ROC curves of the validation cohort and AUC values (AUC, 0.949; 95% CI, 0.886 to 1.000). (D) Calibra-
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Revascularize Acute Ischemic Stroke Patients with Large Vessel 
Occlusion Efficiently in Chinese Tertiary Hospitals: a Multi-
center Randomized Clinical Trial (DIRECT-MT) demonstrated 
that EVT alone was noninferior to combined IV t-PA and EVT 
with respect to functional outcomes, but it was associated 
with lower rates of successful recanalization than the com-
bined therapy.22 Although similar trials (NCT03192332, 
NCT03494920, and ISRCTN80619088) are ongoing,23,24 it is 
questionable whether one strategy (either direct EVT or com-
bined intravenous thrombolysis and EVT) should be the only 
treatment option for all patients with LVO. A certain group of 
patients would benefit from IV t-PA before EVT, whereas direct 
EVT would be better in another group of patients.8 In this con-
text, prediction of early recanalization after t-PA would be 
helpful for deciding the strategy between direct EVT and com-
bined intravenous thrombolysis and EVT. For example, IV t-PA 
before EVT may be considered when the probability of early re-
canalization by IV t-PA is high based on the prediction model. 
When the probability is very low, direct EVT may be considered 
as IV t-PA may increase the risk of bleeding and lead to delay 
the initiation of EVT.
In t-PA treatment, clot volume is an important factor associ-
ated with early recanalization. This study showed that good col-
laterals also enhance the chance for early successful recanaliza-
tion. In a previous study based on perfusion magnetic resonance 
imaging, good collaterals were associated with recanalization 
within 3 hours after t-PA treatment.14 Good collaterals can lead 
to a bidirectional action of t-PA (forward and back flow). This 
may be able to enhance the proteolytic action of t-PA by in-
creasing the surface area contacting the t-PA.14,16,25
Although there have been several prognostic models or scor-
ing systems for estimating safety or efficacy of thrombolytic 
therapy with IV t-PA for acute ischemic stroke, little is known 
on the model for predicting the successful recanalization by IV 
t-PA within 1 hour. In this study, recanalization was assessed 
about 60 minutes after IV t-PA injection, immediately after the 
end of IV t-PA infusion when making a decision regarding fur-
ther EVT is necessary. Therefore, prediction of recanalization at 
this time point is important for determining the treatment 
strategy. We found that only two variables (clot volume and 
good collaterals) were sufficient for reliably predicting recanal-
ization with high performance at this time point. The nomo-
gram that we developed may also be helpful for making a rapid 
decision. 
This study had some limitations. Although collaterals are 
easily determined on CTA, measurement of clot volume re-
quires a software program. Therefore, the wide use of this pre-
diction model is limited because it depends on the availability 
of the software. We only included patients with occlusion of 
the MCA or distal ICA. Thereby, the predictive ability of our 
model for occlusion at other cerebral arterial segments is un-
known. In addition, although we tried to show the 2C model in 
this study could be useful for predicting the early recanaliza-
tion, the rate of early recanalization was low. This might lead 
the relatively low statistical power. So, we thought further 
analysis including larger amount of data would be necessary.
Conclusions
We showed that clot volume and good collaterals were associ-
ated with early recanalization after IV t-PA treatment, and the 
prediction model using clot volume and good collaterals 
showed high performance in the derivation and validation co-
horts. Our model may aid in the decision making with respect 
to the recanalization strategy.
Supplementary materials
Supplementary materials related to this article can be found 
online at https://doi.org/10.5853/jos.2020.03622.
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Supplementary Table 1. Multivariable analyses for early recanalization and the area under curves of models by the timing of follow-up angiographic studies
Variable
≥45 minutes ≤75 minutes
OR (95% CI) P OR (95% CI) P
Clot volume (mm3) 0.980 (0.963–0.997) 0.024 0.972 (0.946–0.999) 0.040
Good collaterals 3.972 (0.840–18.796) 0.082 10.714 (1.790–64.139) 0.009
AUC of model 0.862 0.908
OR, odds ratio; CI, confidence interval; AUC, area under the curve.
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Supplementary Figure 1. Nomogram for predicting early successful recanalization after intravenous tissue plasminogen activator. When using nomogram, 
higher total points based on the sum of the assigned number of points for good collaterals and clot volume were associated with the chance of early recanali-
zation. Firstly, points based on good collateral and clot volume should be calculated. Then, the summation of these points indicates the probability of the early 
recanalization. For example, a patient with good collaterals and clot volume of 50 mm3 would have a total of 108 points (20 points for good collaterals [red 
solid line] and 88 points for clot volume [red dashed line]). The predicted early successful recanalization (blue solid line) is 44.4% for this patient.
